Evaluation of clINical reCovery After a Relapse: a Pilot Study assEssing the Neuronal Effects of D-Aspartate in RR-MS Subjects Treated With IntErferon Beta 1a 44 mcg TIW (INCREASE)
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Interferon beta-1a (Primary) ; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms INCREASE
- Sponsors Merck KGaA
- 12 Mar 2018 Planned initiation date changed from 16 Feb 2018 to 15 Mar 2018.
- 16 Feb 2018 Planned initiation date changed from 5 Jan 2018 to 16 Feb 2018.
- 05 Jan 2018 New trial record